215 related articles for article (PubMed ID: 23372693)
1. Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).
Strohmaier S; Edlinger M; Manjer J; Stocks T; Bjørge T; Borena W; Häggström C; Engeland A; Nagel G; Almquist M; Selmer R; Tretli S; Concin H; Hallmans G; Jonsson H; Stattin P; Ulmer H
PLoS One; 2013; 8(1):e54242. PubMed ID: 23372693
[TBL] [Abstract][Full Text] [Related]
2. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.
Borena W; Edlinger M; Bjørge T; Häggström C; Lindkvist B; Nagel G; Engeland A; Stocks T; Strohmaier S; Manjer J; Selmer R; Tretli S; Concin H; Hallmans G; Jonsson H; Stattin P; Ulmer H
PLoS One; 2014; 9(2):e89368. PubMed ID: 24586723
[TBL] [Abstract][Full Text] [Related]
3. Body mass index, cholesterol level and risk of lung cancer in Lithuanian men.
Everatt R; Virvičiūtė D; Kuzmickienė I; Tamošiūnas A
Lung Cancer; 2014 Sep; 85(3):361-5. PubMed ID: 25084690
[TBL] [Abstract][Full Text] [Related]
4. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
[TBL] [Abstract][Full Text] [Related]
5. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.
Stocks T; Rapp K; Bjørge T; Manjer J; Ulmer H; Selmer R; Lukanova A; Johansen D; Concin H; Tretli S; Hallmans G; Jonsson H; Stattin P
PLoS Med; 2009 Dec; 6(12):e1000201. PubMed ID: 20027213
[TBL] [Abstract][Full Text] [Related]
6. Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women.
Teleka S; Häggström C; Nagel G; Bjørge T; Manjer J; Ulmer H; Liedberg F; Ghaderi S; Lang A; Jonsson H; Jahnson S; Orho-Melander M; Tretli S; Stattin P; Stocks T
Int J Cancer; 2018 Dec; 143(12):3071-3082. PubMed ID: 29756343
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and rare gynecological cancers in the metabolic syndrome and cancer project (Me-Can).
Nagel G; Concin H; Bjørge T; Rapp K; Manjer J; Hallmans G; Diem G; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stocks T; Tretli S; Ulmer H; Stattin P; Lukanova A
Ann Oncol; 2011 Jun; 22(6):1339-1345. PubMed ID: 20966183
[TBL] [Abstract][Full Text] [Related]
8. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
Borena W; Strohmaier S; Lukanova A; Bjørge T; Lindkvist B; Hallmans G; Edlinger M; Stocks T; Nagel G; Manjer J; Engeland A; Selmer R; Häggström C; Tretli S; Concin H; Jonsson H; Stattin P; Ulmer H
Int J Cancer; 2012 Jul; 131(1):193-200. PubMed ID: 21805476
[TBL] [Abstract][Full Text] [Related]
9. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
Nagel G; Bjørge T; Stocks T; Manjer J; Hallmans G; Edlinger M; Häggström C; Engeland A; Johansen D; Kleiner A; Selmer R; Ulmer H; Tretli S; Jonsson H; Concin H; Stattin P; Lukanova A
Br J Dermatol; 2012 Jul; 167(1):59-67. PubMed ID: 22530854
[TBL] [Abstract][Full Text] [Related]
10. Pooled cohort study on height and risk of cancer and cancer death.
Wirén S; Häggström C; Ulmer H; Manjer J; Bjørge T; Nagel G; Johansen D; Hallmans G; Engeland A; Concin H; Jonsson H; Selmer R; Tretli S; Stocks T; Stattin P
Cancer Causes Control; 2014 Feb; 25(2):151-9. PubMed ID: 24173535
[TBL] [Abstract][Full Text] [Related]
11. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).
Lindkvist B; Almquist M; Bjørge T; Stocks T; Borena W; Johansen D; Hallmans G; Engeland A; Nagel G; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
Cancer Causes Control; 2013 Jan; 24(1):107-16. PubMed ID: 23149498
[TBL] [Abstract][Full Text] [Related]
12. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria.
Rapp K; Schroeder J; Klenk J; Ulmer H; Concin H; Diem G; Oberaigner W; Weiland SK
Diabetologia; 2006 May; 49(5):945-52. PubMed ID: 16557372
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
Bjørge T; Lukanova A; Jonsson H; Tretli S; Ulmer H; Manjer J; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Häggström C; Stattin P; Engeland A
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1737-45. PubMed ID: 20615887
[TBL] [Abstract][Full Text] [Related]
14. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.
Lindkvist B; Johansen D; Stocks T; Concin H; Bjørge T; Almquist M; Häggström C; Engeland A; Hallmans G; Nagel G; Jonsson H; Selmer R; Ulmer H; Tretli S; Stattin P; Manjer J
BMC Cancer; 2014 Feb; 14():103. PubMed ID: 24548688
[TBL] [Abstract][Full Text] [Related]
15. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
Häggström C; Stocks T; Rapp K; Bjørge T; Lindkvist B; Concin H; Engeland A; Manjer J; Ulmer H; Selmer R; Tretli S; Hallmans G; Jonsson H; Stattin P
Int J Cancer; 2011 Apr; 128(8):1890-8. PubMed ID: 20568111
[TBL] [Abstract][Full Text] [Related]
17. Fasting serum glucose level and cancer risk in Korean men and women.
Jee SH; Ohrr H; Sull JW; Yun JE; Ji M; Samet JM
JAMA; 2005 Jan; 293(2):194-202. PubMed ID: 15644546
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project.
Stocks T; Van Hemelrijck M; Manjer J; Bjørge T; Ulmer H; Hallmans G; Lindkvist B; Selmer R; Nagel G; Tretli S; Concin H; Engeland A; Jonsson H; Stattin P
Hypertension; 2012 Apr; 59(4):802-10. PubMed ID: 22353615
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and esophageal and gastric cancer.
Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y
Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604
[TBL] [Abstract][Full Text] [Related]
20. Metabolic factors associated with risk of renal cell carcinoma.
Häggström C; Rapp K; Stocks T; Manjer J; Bjørge T; Ulmer H; Engeland A; Almqvist M; Concin H; Selmer R; Ljungberg B; Tretli S; Nagel G; Hallmans G; Jonsson H; Stattin P
PLoS One; 2013; 8(2):e57475. PubMed ID: 23468995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
